Q1 What age are you?

Similar documents
WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Alcohol-related harm in Europe and the WHO policy response

European status report on alcohol and health Leadership, awareness and commitment

LEBANON. WCPT COUNTRY PROFILE December 2018

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Engagement in language assessment / Regions of Europe

DENMARK. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Where we stand in EFORT

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

European Status report on Alcohol and Health

Real Life, Real PD Survey

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Smokefree Policies in Europe: Are we there yet?

The cancer burden in the European Union and the European Region: the current situation and a way forward

Development of Palliative Care services in different countries

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Highlighting in the WHO European Region:

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Overall survival: 1 st line therapy

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

European Collaboration on Dementia. Luxembourg, 13 December 2006

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Prevention of Oral Cancer Special Interest Working Group

Overview of drug-induced deaths in Europe - What does the data tell us?

Summary. Primary care data. Week 49/2014. Season

SVERIGES DÖVAS UNGDOMSFÖRBUND (SDUF), SWEDISH YNAD

European Association of Dental Public Health Prevention of Oral Cancer

Percutaneous Mitral Valve Therapies

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Cross Border Genetic Testing for Rare Diseases

11 Melanoma of the skin

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Access to treatment and disease burden

Table 7.1 Summary information for lung cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland,

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

Cannabis policies & cannabis use

Inequality in injury risks

Cardiovascular disease in Europe: epidemiological update 2016

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Rheumatoid Arthritis Disease Burden and Access to Treatment

Terms and Conditions. VISA Global Customer Assistance Services

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Monthly measles and rubella monitoring report

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

European Community Pharmacy: a reference in Public Health

Health systems requirements for viral hepatitis elimination: Are we 'Flying Blind' in our efforts?

Better Health for All in Latvia

The EHRA White Book 2010

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

Best practices in collecting and processing data in CRC screening and after it

Welcome to the new EURO Immunization Monitor

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Report summary. From 01/01/2014 to 11/05/2014

Where do EU Contries set the limit for low risk drinking.

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Positioning health equity and the social determinants of health on the regional development agenda Investment for health and development in Slovenia

State of Health In EU: Community Pharmacy Contribution

Palliative nursing care of children and young people across Europe

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

THE CARE WE PROMISE FACTS AND FIGURES 2017

15 yers of Czech National Breast Cancer Screening Programme

Update on EEA s near real time air quality data exchange

Transcription:

Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56% 28 3.97% 20 4.76% 24 4.96% 25 5.75% 29 4.96% 25 10.32% 52 TOTAL 504 1 / 26

Q2 What is your gender? Answered: 504 Skipped: 0 Female Male Prefer not to say Other 85.91% 433 12.70% 64 0.40% 2 0.99% 5 TOTAL 504 2 / 26

Q3 In what country do you live? Answered: 504 Skipped: 0 Albania Andorra Armenia Austria Azerbaijan Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Georgia Germany Greece Hungary Iceland Ireland Italy Kazakhstan Kosovo Latvia Liechtenstein Lithuania Luxembourg Macedonia (FYROM) 0.40% 2 2.18% 11 0.20% 1 3.37% 17 0.40% 2 0.40% 2 1.39% 7 0.20% 1 0.20% 1 0.79% 4 3 / 26

Malta Moldova Monaco Montenegro Netherlands Norway Poland Portugal Romania Russia San Marino Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey Ukraine United Kingdom (UK) Vatican City (Holy See) 4.17% 21 67.86% 342 0.60% 3 0.79% 4 1.19% 6 0.40% 2 15.48% 78 TOTAL 504 4 / 26

Q4 Are you currently: Answered: 496 Skipped: 8 Studying full-time Studying part-time Employed full-time Employed part-time Unemployed and seeking work Unemployed and not seeking work Self-employed 6.05% 30 10.08% 50 8.47% 42 9.68% 48 2.22% 11 62.90% 312 2.22% 11 Total Respondents: 496 5 / 26

Q5 What level of education have you achieved so far? Answered: 497 Skipped: 7 Completed high school/second level Certificate Diploma Bachelor's Degree Master's Degree PhD Other (please specify) 36.82% 183 6.04% 30 8.65% 43 21.53% 107 8.05% 40 0.40% 2 18.51% 92 TOTAL 497 6 / 26

Q6 What neurological disorder(s) are you affected by? (Tick all that apply) Answered: 504 Skipped: 0 Myalgic Encephalomyelitis (ME) Chronic pain Migraine Other (please specify) Restless Legs Syndrome (RLS) ADHD Multiple Sclerosis (MS) Acquired Brain Injury (ABI) Brain Tumour Dystonia Tourette Syndrome Myasthenia Gravis Spina Bifida and Hydrocephalus Ataxia Dementia Epilepsy Huntington s disease Motor Neurone Disease (MND) Parkinson s disease Stroke 100.00% 504 22.82% 115 17.26% 87 7.54% 38 6.35% 32 4.56% 23 1.19% 6 0.60% 3 0.60% 3 0.60% 3 0.40% 2 0.20% 1 0.20% 1 Total Respondents: 504 7 / 26

Q7 Do you take prescribed medication for the above? Answered: 501 Skipped: 3 Yes No Previously, but not now 40.92% 205 52.10% 261 6.99% 35 TOTAL 501 8 / 26

Q8 Are you currently under treatment of a specialist/neurologist? Answered: 500 Skipped: 4 Yes No Previously, but not now 19.20% 96 64.20% 321 16.60% 83 TOTAL 500 9 / 26

Q9 Are other members of your family affected by a neurological disorder? Answered: 502 Skipped: 2 Yes No Unsure 46.41% 233 39.64% 199 13.94% 70 TOTAL 502 10 / 26

Q10 How well do you feel your family understand your condition? Answered: 484 Skipped: 20 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 484 57 27,670 484 11 / 26

Q11 How well do you feel your friends understand your condition? Answered: 481 Skipped: 23 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 481 38 18,393 481 12 / 26

Q12 How comfortable would you feel discussing your brain disorder with a new friend? Answered: 479 Skipped: 25 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 479 44 21,103 479 13 / 26

Q13 How comfortable would you feel discussing your brain disorder with an employer? Answered: 477 Skipped: 27 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 477 28 13,501 477 14 / 26

Q14 Do you feel public understanding of your condition is: Answered: 478 Skipped: 26 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 478 14 6,505 478 15 / 26

Q15 Do you feel public understanding of brain disorders generally is: Answered: 478 Skipped: 26 AVERAGE NUMBER TOTAL NUMBER Total Respondents: 478 26 12,648 478 16 / 26

Q16 Are there any digital tools which help you with the management of your neurological disorder? Answered: 487 Skipped: 17 Yes No I tried something but stopped using it 16.22% 79 77.00% 375 6.78% 33 TOTAL 487 17 / 26

Q17 If 'Yes', what are they called? Answered: 68 Skipped: 436 18 / 26

Q18 If you previously tried a digital tool but stopped using it, why was that? Answered: 79 Skipped: 425 Too difficult to use It was boring It seemed ineffective I'm worried about how my personal health data might be used Other (please specify) 31.65% 25 6.33% 5 40.51% 32 13.92% 11 22.78% 18 Total Respondents: 79 19 / 26

Q19 Have you ever taken part in any awareness-raising activities relating to brain disorder/your own condition? Answered: 483 Skipped: 21 Yes No 39.96% 193 60.04% 290 TOTAL 483 20 / 26

Q20 If No, is this something you would be interested in? Answered: 287 Skipped: 217 Yes No 63.41% 182 36.59% 105 TOTAL 287 21 / 26

Q21 Are you a member of a patient organisation? Answered: 480 Skipped: 24 Yes No In the past, but not now 48.75% 234 46.25% 222 5.00% 24 TOTAL 480 22 / 26

Q22 If No, would you be interested in finding out more about one? Answered: 196 Skipped: 308 Yes No 63.78% 125 36.22% 71 TOTAL 196 23 / 26

Q23 Patient organisations need to know about the issues that affect you most as a young person with a neurological condition. Please arrange the issues below so that the most serious issue is at the top (1) and the least serious is at the bottom (8). Answered: 451 Skipped: 53 Access to employment 1 2 3 4 5 6 7 8 TOTAL SCORE 5.54% 25 7.10% 32 8.20% 37 7.76% 35 15.30% 69 19.96% 90 18.85% 85 17.29% 78 451 3.58 Access to education 4.66% 21 6.43% 29 7.54% 34 11.53% 52 15.74% 71 17.07% 77 23.28% 105 13.75% 62 451 3.60 Depression / anxiety 4.21% 19 6.43% 29 13.08% 59 13.97% 63 16.63% 75 12.86% 58 9.53% 43 23.28% 105 451 3.75 Relationships and sexual health 3.77% 17 8.65% 39 8.43% 38 18.85% 85 13.97% 63 14.19% 64 16.41% 74 15.74% 71 451 3.82 Cost of medication/treatment 4.21% 19 9.98% 45 13.08% 59 12.42% 56 11.75% 53 17.07% 77 12.86% 58 18.63% 84 451 3.87 Stigma surrounding brain disease 13.08% 59 21.06% 95 18.85% 85 13.75% 62 12.20% 55 8.20% 37 7.98% 36 4.88% 22 451 5.28 Isolation 19.73% 89 20.40% 92 22.39% 101 13.97% 63 9.31% 42 6.21% 28 5.10% 23 2.88% 13 451 5.74 Access to medication/treatment 44.79% 202 19.96% 90 8.43% 38 7.76% 35 5.10% 23 4.43% 20 5.99% 27 3.55% 16 451 6.37 24 / 26